Correlation Engine 2.0
Clear Search sequence regions

  • giant cell (3)
  • glucocorticoid (5)
  • humans (1)
  • patients (1)
  • receptor (1)
  • stroke (1)
  • tocilizumab (1)
  • Sizes of these terms reflect their relevance to your search.

    Giant cell arteritis (GCA) is the most common idiopathic systemic vasculitis in the age group over 50 years. It requires prompt diagnostics and treatment to avoid severe complications, such as visual loss or stroke. The tendency to relapse makes a glucocorticoid (GC) treatment necessary for several years and sometimes lifelong, which increases the risk of GC-induced long-term side effects. Therefore, additive GC-sparing treatment is recommended in the majority of patients. For this purpose, the anti-IL‑6 receptor antibody tocilizumab is available as an approved substance for subcutaneous application; alternatively, methotrexate (MTX) can be used (off-label). © 2021. The Author(s).


    Markus Kraemer, Jana Becker, Thorsten Alexander Bley, Andreas Steinbrecher, Jens Minnerup, Bernhard Hellmich. Diagnostics and treatment of giant cell arteritis]. Der Nervenarzt. 2022 Aug;93(8):819-827

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 34734295

    View Full Text